F. Orlandi
- Biomaterials top 2%
- Oncology top 5%
- Biomedical Engineering top 5%
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- D G KiebackCraig TendlerL. MellarsMoshe InbarLeila AllandPiotr TomczakArmando SantoroNely Wigler
- Topics
- Cancer Immunotherapy and Biomarkers (4 papers)Lung Cancer Treatments and Mutations (3 papers)Cancer Genomics and Diagnostics (2 papers)
- Journals
- Annals of Oncology
- Partner nations
- United StatesJapanChile
In The Last Decade
F. Orlandi
6 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Biomaterials 642
- Oncology 507
- Biomedical Engineering 494
- Molecular Biology 334
- Cardiology and Cardiovascular Medicine 248
Countries citing papers authored by F. Orlandi
This map shows the geographic impact of F. Orlandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Orlandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Orlandi more than expected).
Fields of papers citing papers by F. Orlandi
This network shows the impact of papers produced by F. Orlandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Orlandi. The network helps show where F. Orlandi may publish in the future.
Co-authorship network of co-authors of F. Orlandi
This figure shows the co-authorship network connecting the top 25 collaborators of F. Orlandi. A scholar is included among the top collaborators of F. Orlandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Orlandi. F. Orlandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 9 | |
| 4 | 7 | |
| 5 | 5 | |
| 6 | Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerbreakdown → | 1311 |
About F. Orlandi
F. Orlandi is a scholar working on Oncology, Gastroenterology and Cancer Research, having authored 6 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Biomaterials (642 citations), Oncology (507 citations) and Biomedical Engineering (494 citations). F. Orlandi has collaborated with scholars based in United States, Japan and Chile. Frequent co-authors include D G Kieback, Craig Tendler, L. Mellars, Moshe Inbar, Leila Alland, Piotr Tomczak, Armando Santoro, Nely Wigler, Eva‐Maria Grischke and Raphael Catane. Their work appears in journals such as Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.